PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11099465-1	2000	We have previously demonstrated that halofuginone, a low molecular weight quinazolinone alkaloid, is a potent inhibitor of collagen alpha1(I) and matrix metalloproteinase 2 (MMP-2) gene expression.	halofuginone	37-49	matrix metallopeptidase 2	Mus musculus	146-172	
11099465-1	2000	We have previously demonstrated that halofuginone, a low molecular weight quinazolinone alkaloid, is a potent inhibitor of collagen alpha1(I) and matrix metalloproteinase 2 (MMP-2) gene expression.	halofuginone	37-49	matrix metallopeptidase 2	Mus musculus	174-179	
11099465-1	2000	We have previously demonstrated that halofuginone, a low molecular weight quinazolinone alkaloid, is a potent inhibitor of collagen alpha1(I) and matrix metalloproteinase 2 (MMP-2) gene expression.	Quinazolinones	74-87	matrix metallopeptidase 2	Mus musculus	174-179	
11099465-6	2000	The most conclusive anti-angiogenic activity of halofuginone was demonstrated in vivo (mouse corneal micropocket assay) by showing a marked inhibition of basic fibroblast growth factor (bFGF) -induced neovascularization in response to systemic administration of halofuginone, either i.p.	halofuginone	48-60	fibroblast growth factor 2	Mus musculus	154-184	
11099465-6	2000	The most conclusive anti-angiogenic activity of halofuginone was demonstrated in vivo (mouse corneal micropocket assay) by showing a marked inhibition of basic fibroblast growth factor (bFGF) -induced neovascularization in response to systemic administration of halofuginone, either i.p.	halofuginone	48-60	fibroblast growth factor 2	Mus musculus	186-190	
11099465-6	2000	The most conclusive anti-angiogenic activity of halofuginone was demonstrated in vivo (mouse corneal micropocket assay) by showing a marked inhibition of basic fibroblast growth factor (bFGF) -induced neovascularization in response to systemic administration of halofuginone, either i.p.	halofuginone	262-274	fibroblast growth factor 2	Mus musculus	186-190